Clincosm LogoSign in Get a demo

Age-Related Macular Degeneration (AMD)

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rehabilitating Vision Loss in Veterans With Age-Related Macular

Not yet recruiting
  • Age-related Macular Degeneration (AMD)
  • Study-specific rehabilitation (SSR) procedures
  • Augusta, Georgia
    Charlie Norwood VA Medical Center, Augusta, GA
Mar 10, 2023

Age-related Macular Degeneration (AMD) Trial in Créteil (Dimethyl Fumarate (TECFIDERA™), No active : no treatment)

Recruiting
  • Age-related Macular Degeneration (AMD)
  • Dimethyl Fumarate (TECFIDERA™)
  • No active : no treatment
  • Créteil, Val De Marne, France
    Centre intercommunal de Créteil
Aug 2, 2022

Neovascular Age-related Macular Degeneration

Completed
  • Age-related Macular Degeneration (AMD)
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Ocular Adverse Events in Neovascular Agerelated Macular

Completed
  • Age-related Macular Degeneration (AMD)
  • Aflibercept
  • +2 more
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Ocular Adverse Events in Neovascular Age-related Macular

Completed
  • Age-related Macular Degeneration (AMD)
  • Aflibercept
  • +2 more
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Neovascular Age-related Macular Degeneration

Completed
  • Age-related Macular Degeneration (AMD)
  • East Hanover, New Jersey
    Novartis Pharmaceuticals
Oct 19, 2021

Number of Patient Eyes That Remained on or Switched to Anti-VEGF

Completed
  • Age-related Macular Degeneration (AMD)
  • East Hanover, New Jersey
    Novartis Investigational site
Oct 6, 2021

Neovascular Age-related Macular Degeneration Enrolled in

Completed
  • Age-related Macular Degeneration (AMD)
  • All participants
  • East Hanover, New Jersey
    Novartis Investigative Site
Oct 6, 2021

Age-related Macular Degeneration (AMD) Trial in Worldwide (ranibizumab)

Completed
Has Results
  • Age-related Macular Degeneration (AMD)
  • ranibizumab
  • Vienna, Austria
  • +57 more
Sep 2, 2021

Age-related Macular Degeneration (AMD) Trial (brolucizumab)

Withdrawn
  • Age-related Macular Degeneration (AMD)
  • (no location specified)
Sep 21, 2021

Age-related Macular Degeneration (AMD) Trial in Limoges (Interviews)

Unknown status
  • Age-related Macular Degeneration (AMD)
  • Interviews
  • Limoges, France
    Service d'Ophtalmologie
Jun 27, 2019

Age-related Macular Degeneration (AMD) Trial in Fort Worth (LMG324, Ranibizumab 0.5 mg, Sham)

Terminated
  • Age-related Macular Degeneration (AMD)
  • LMG324
  • +2 more
  • Fort Worth, Texas
    Call Alcon Call Center for Trial Locations
Jun 3, 2019

Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), Mid-peripheral Drusen Formation Trial in Eagan

Unknown status
  • Diabetic Retinopathy (DR)
  • +3 more
  • Photobiomodulation
  • Ketogenic diet
  • Eagan, Minnesota
    Yankee Eye Clinic
Feb 28, 2019

Geographic Atrophy in AMD Patients Using Nidek MP-3

Completed
  • Age-related Macular Degeneration (AMD)
  • Nidek MP-3
  • Pasadena, California
    Doheny Eye Centers UCLA
Feb 12, 2019

naïve Age-related Macular Degeneration:Model Adapted to French

Unknown status
  • Age-related Macular Degeneration (AMD)
    • (no location specified)
    Feb 1, 2019

    Degenerative and Inflammatory Eye Diseases

    Completed
    • Diabetic Retinopathy
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 7, 2018

      Safe Use Information for Aflibercept in Canada

      Completed
      • Age-related Macular Degeneration (AMD)
      • +2 more
      • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
      • Many Locations, Canada
        (unnamed)
      Mar 20, 2017

      Age-Related Macular Degeneration (AMD) Trial in United States (PAN-90806 Ophthalmic Solution, Lucentis)

      Completed
      • Age-Related Macular Degeneration (AMD)
      • Colorado Springs, Colorado
      • +21 more
      Sep 27, 2016

      Age-related Macular Degeneration (AMD) Trial in Worldwide (Lutein-enriched-egg beverage (NWT-02), Placebo)

      Completed
      • Age-related Macular Degeneration (AMD)
      • Lutein-enriched-egg beverage (NWT-02)
      • Placebo
      • Boston, Massachusetts
      • +3 more
      Sep 20, 2016

      Age-Related Macular Degeneration (AMD) Trial in London (Tetracaine, Cocaine, Lidocaine)

      Completed
      • Age-Related Macular Degeneration (AMD)
      • London, Ontario, Canada
        Ivey Eye Institute
      Apr 17, 2012

      A Study Of Early Markers Of Choroidal Neovascularization

      Terminated
      • Choroidal Neovascularization (CNV)
      • +2 more
      • no drug
      • Milano, Italy
      • +2 more
      Nov 9, 2010

      Age-Related Macular Degeneration (AMD) Trial in Abilene (pegaptanib sodium (Macugen))

      Unknown status
      • Age-Related Macular Degeneration (AMD)
      • pegaptanib sodium (Macugen)
      • Abilene, Texas
        Retina Research Institute of Texas, LLC
      Jan 12, 2007